Información de Indivior PLC, dividendo de Indivior PLC, actividades de los accionistas y más

Más Datos de Indivior PLC Compañía

Indivior PLC is a pharmaceutical company. The Company is engaged in developing medicines to treat substance use disorders (SUD), serious mental illnesses, and opioid overdose. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder, and co-morbidities, including schizophrenia. Its core products include SUBLOCADE (buprenorphine extended release) monthly injection; SUBOXONE Film (buprenorphine and naloxone sublingual film); SUBOXONE Tablet (buprenorphine and naloxone sublingual tablets), and SUBUTEX Tablet (buprenorphine sublingual tablets). Its products for the treatment of opioid disorders (OUD) are OPVEE (nalmefene) nasal spray for opioid overdose reversal, and PERSERIS (risperidone) extended-release injectable suspension for the treatment of schizophrenia in adults in the United States. Its portfolio of products is available in 37 countries.

Información de Indivior PLC



Símbolo de cotizaciónINDV

Nombre de la empresaIndivior PLC

Fecha de salida a bolsaDec 24, 2014

Director ejecutivoMr. Joseph J. (Joe) Ciaffoni

Número de empleados1030

Tipo de seguridadOrdinary Share

Fin del año fiscalDec 24

Dirección234 Bath Road

CiudadSLOUGH

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited Kingdom

Código postalSL1 4EE

Teléfono448043791090

Sitio Webhttps://www.indivior.com/en

Símbolo de cotizaciónINDV

Fecha de salida a bolsaDec 24, 2014

Director ejecutivoMr. Joseph J. (Joe) Ciaffoni

Ejecutivos de Indivior PLC



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Vishal Kalia

Chief Impact and Strategy Officer

137.46K

+3.25%

Mr. Christian Heidbreder

Chief Scientific Officer

132.64K

+42.74%

Ms. Cynthia (Cindy) Cetani

Chief Integrity and Compliance Officer

121.74K

--

Mr. Hillel West

Chief Manufacturing and Supply Officer

121.72K

+338.91%

Mr. Joseph J. (Joe) Ciaffoni

Chief Executive Officer, Director

56.00K

--

Mr. Daniel A. (Dan) Ninivaggi, J.D.

Non-Executive Independent Director

15.00K

--

Ms. Juliet Thompson

Senior Non-Executive Independent Director

9.63K

+150.00%

Dr. Keith Humphreys

Non-Executive Independent Director

3.88K

+63.05%

Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.

Chief Legal Officer

760.00

--

Mr. Stuart (Tony) Kingsley

Independent Non-Executive Director

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Vishal Kalia

Chief Impact and Strategy Officer

137.46K

+3.25%

Mr. Christian Heidbreder

Chief Scientific Officer

132.64K

+42.74%

Ms. Cynthia (Cindy) Cetani

Chief Integrity and Compliance Officer

121.74K

--

Mr. Hillel West

Chief Manufacturing and Supply Officer

121.72K

+338.91%

Mr. Joseph J. (Joe) Ciaffoni

Chief Executive Officer, Director

56.00K

--

Mr. Daniel A. (Dan) Ninivaggi, J.D.

Non-Executive Independent Director

15.00K

--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Sin datos

Por regiónUSD

Nombre

Ganancia

Proporción

United States

256.00M

84.77%

Rest of World

46.00M

15.23%

Por negocio

Por región

Sin datos

Estadísticas de accionistas

Actualizado: vie., 15 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

Oaktree Capital Management, L.P.

8.82%

Deerfield Management Company, L.P.

8.46%

Two Seas Capital LP

7.41%

Goldman Sachs International

7.19%

BlackRock Investment Management (UK) Ltd.

6.62%

Otro

61.50%

Accionistas

Proporción

Oaktree Capital Management, L.P.

8.82%

Deerfield Management Company, L.P.

8.46%

Two Seas Capital LP

7.41%

Goldman Sachs International

7.19%

BlackRock Investment Management (UK) Ltd.

6.62%

Otro

61.50%

Tipos de accionistas

Accionistas

Proporción

Hedge Fund

40.46%

Investment Advisor/Hedge Fund

24.19%

Investment Advisor

15.17%

Research Firm

13.06%

Individual Investor

3.87%

Pension Fund

0.44%

Bank and Trust

0.31%

Family Office

0.31%

Insurance Company

0.04%

Otro

2.14%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

372

118.02M

94.53%

+2.51M

2025Q2

354

123.13M

98.21%

+4.02M

2025Q1

380

119.99M

96.15%

-1.70M

2024Q4

382

116.83M

93.64%

-10.43M

2024Q3

369

117.73M

91.72%

-15.91M

2024Q2

352

119.29M

90.10%

-8.99M

2024Q1

341

129.79M

96.57%

+3.79M

2023Q4

322

124.43M

92.28%

+2.93M

2023Q3

321

114.40M

84.40%

+17.06M

2023Q2

296

115.50M

83.90%

+12.51M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Oaktree Capital Management, L.P.

11.01M

8.82%

--

Jun 30, 2025

Deerfield Management Company, L.P.

10.57M

8.47%

--

Jun 30, 2025

Two Seas Capital LP

10.33M

8.28%

-1.33M

-11.43%

Sep 03, 2025

Goldman Sachs International

8.97M

7.19%

+759.17K

+9.24%

Jun 30, 2025

BlackRock Investment Management (UK) Ltd.

8.27M

6.63%

+8.24M

+28135.71%

Jun 27, 2025

Madison Avenue Partners LP

7.92M

6.35%

+130.09K

+1.67%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

5.04M

4.04%

+5.03M

+68055.48%

Jun 30, 2025

Rubric Capital Management LP

4.65M

3.72%

-55.00K

-1.17%

Jun 30, 2025

Point72 Asset Management, L.P.

3.57M

2.86%

+1.69M

+89.42%

Jun 30, 2025

The Vanguard Group, Inc.

5.63M

4.51%

+1.02M

+22.15%

Jun 30, 2025

ETFs relacionados



Actualizado: jue., 6 de nov

Nombre

Proporción

Lattice Hartford Multifactor Small Cap ETF

0.84%

Federated Hermes MDT Small Cap Core ETF

0.36%

Janus Henderson Small Cap Growth Alpha ETF

0.35%

ProShares Ultra Nasdaq Biotechnology

0.31%

Invesco Nasdaq Biotechnology ETF

0.3%

Franklin US Small Cap Multifactor Index ETF

0.27%

Vanguard US Multifactor ETF

0.24%

Pacer US Small Cap Cash Cows ETF

0.22%

First Trust Active Factor Small Cap ETF

0.22%

Principal U.S. Small-Cap ETF

0.16%

Lattice Hartford Multifactor Small Cap ETF

Proporción0.84%

Federated Hermes MDT Small Cap Core ETF

Proporción0.36%

Janus Henderson Small Cap Growth Alpha ETF

Proporción0.35%

ProShares Ultra Nasdaq Biotechnology

Proporción0.31%

Invesco Nasdaq Biotechnology ETF

Proporción0.3%

Franklin US Small Cap Multifactor Index ETF

Proporción0.27%

Vanguard US Multifactor ETF

Proporción0.24%

Pacer US Small Cap Cash Cows ETF

Proporción0.22%

First Trust Active Factor Small Cap ETF

Proporción0.22%

Principal U.S. Small-Cap ETF

Proporción0.16%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos